Member Biography

Naveen Manchanda, M.B.B.S.
Naveen Manchanda

Naveen Manchanda, M.B.B.S.

535 Barnhill Drive
RT 473
Indianapolis, IN 46202
Phone: (317) 944-0920
Fax: (317) 274-0396

Research Program Membership

Affiliate member:

Associate Professor of Clinical Medicine
Department of Medicine
Division of Hematology/Oncology
IU School of Medicine

Dr. Manchanda's research interests include:

1. Setting up of Anticoagulation clinics: Deep vein thrombosis and pulmonary embolism remain as important causes of morbidity and mortality in patients with or without cancer. Several thousand patients in the Indianapolis and surrounding areas receive anticoagulation with Warfarin and Heparin like drugs to enable them to treat and avoid potentially life-threatening blood clots. Careful control of these patients while they are on these medications to promote efficacy and avoid complications requires constant blood checks with reporting and adjusting of medications. Such repetitive tests are best monitored and responses standardized in Anticoagulation Clinics. I plan to help set up such a facility at the IU Simon Cancer Center and affiliated Clarian facilities. 2. Pharmacogenomic study of Warfarin therapy: Warfarin is a commonly used medication to prevent blood clots. Complications due to too much or too little of an effect of this drug can be hazardous. Recently, it has been known that patients react to Warfarin depending on how they metabolize the drug. This individualized drug response is the basis of Pharmacogenomics. In collaboration with Dr. David Flockhart and colleagues, I plan to start utilizing these tools to predict and promote appropriately dosed drug therapy. 2. Thrombotic Microangiopathies such as Thrombotic Thrombocytopenic Purpure (TTP) and atypical Hemolytic Uremic Syndrome (aHUS)remain enigmatic puzzles of the vascular system. Both timely recognition and treatment of these illnesses is of paramount importance. We have initiated protocols for treatment of aHUS with newer agents targeting the complement pathway, especially so after renal transplantation. Use of these newer agents remain as challenges as regards the duration of treatment and organ survival.

Importing from PubMed - Please Wait...Importing from PubMed, Please Wait

More Publications »

Fellowship - University of Wisconsin Hospital and Clinics, Madison, WI 1994-1997

Residency - University of Wisconsin Hospital and Clinics, Madison, WI 1990-1994

Post-doctoral Fellowship - University of Wisconsin, Madison, WI 1987-1990

Fellowship - Indian Institute of Chemical Biology, Calcutta, India 1986-1987

M.B.B.S. - Christian Medical College and Hospital, Veloore, India 1979-1985